Drug Shortage Report for CHORIONIC GONADOTROPIN FOR INJECTION, USP

Last updated on 2022-02-04 History
Report ID 144342
Drug Identification Number 02247459
Brand name CHORIONIC GONADOTROPIN FOR INJECTION, USP
Common or Proper name Chorionic Gonadotropin for Injection, USP 10 000 USP units MD Vial 10 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CHORIONIC GONADOTROPIN
Strength(s) 10000UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR
Packaging size 10 mL
ATC code G03GA
ATC description GONADOTROPHINS AND OTHER OVULATION STIMULANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-08-19
Estimated end date 2022-01-31
Actual end date 2022-01-31
Shortage status Resolved
Updated date 2022-02-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2022-02-04 French Compare
v13 2022-02-04 English Compare
v12 2022-01-11 French Compare
v11 2022-01-11 English Compare
v10 2021-12-08 French Compare
v9 2021-12-08 English Compare
v8 2021-12-06 French Compare
v7 2021-12-06 English Compare
v6 2021-12-06 English Compare
v5 2021-09-24 French Compare
v4 2021-09-24 English Compare
v3 2021-08-20 English Compare
v2 2021-08-19 French Compare
v1 2021-08-19 English Compare

Showing 1 to 14 of 14